Calidi Biotherapeutics (CLDI) Cash from Operations (2022 - 2025)
Calidi Biotherapeutics' quarterly Cash from Operations came in at 5093000.0 in Q4 2025, up 6.09% year-on-year from 4800858.51 in Q4 2024, and down 21.26% quarter-over-quarter from 4200000.0 in Q3 2025.
Calidi Biotherapeutics has reported Cash from Operations for 4 years, with the latest figure at 5093000.0 in Q4 2025.
- For the quarter ending Q4 2025, Cash from Operations rose 6.09% year-over-year to 5093000.0; the trailing twelve-month figure through Dec 2025 stood at 21293000.0 (down 8.12% YoY), and the FY2025 full-year result was 21293000.0, down 8.12% from the prior year.
- Cash from Operations for Q4 2025 stood at 5093000.0, down from 4200000.0 in the prior quarter.
- The five-year high for Cash from Operations was 268679.0 in Q2 2022, with the low at 13517000.0 in Q3 2023.
- Average Cash from Operations over 4 years is 5074000.0, with a median of 5019500.0 recorded in 2024.
- Year-over-year, Cash from Operations sank 1825.35% in 2023 and surged 63.41% in 2024.
- Tracing CLDI's Cash from Operations over 4 years: stood at 3876000.0 in 2022, then sank by 33.8% to 5186000.0 in 2023, then retreated by 4.57% to 5423000.0 in 2024, then rose by 6.09% to 5093000.0 in 2025.
- The last three Cash from Operations figures came in at 5093000.0 (Q4 2025), 4200000.0 (Q3 2025), and 4900000.0 (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,638,563.89 Bn | 1,638,563.89 Bn | - | -1.67 Mn |
| 2 | Alterity Therapeutics | 767,934.24 Bn | 767,934.20 Bn | - | - |
| 3 | Legend Biotech | 2,937.00 Bn | 2,936.10 Bn | 242.10 Mn | -12.20 Mn |
| 4 | Nanobiotix | 2,282.79 Bn | 2,282.72 Bn | - | - |
| 5 | Akari Therapeutics | 2,169.69 Bn | 2,169.69 Bn | - | -2.49 Mn |
| 6 | Vertex Pharmaceuticals | 110.41 Bn | 103.16 Bn | 2.59 Bn | 1.43 Bn |
| 7 | Regeneron Pharmaceuticals | 66.44 Bn | 57.69 Bn | 3.31 Bn | 1.08 Bn |
| 8 | Evaxion A | 65.44 Bn | 65.42 Bn | - | - |
| 9 | Alnylam Pharmaceuticals | 39.53 Bn | 36.52 Bn | 959.66 Mn | 70.50 Mn |
| 10 | Calidi Biotherapeutics | - | - | - | -5.09 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -5.09 Mn |
| Dec 31, 2025 | -5.09 Mn |
| Sep 30, 2025 | -4.20 Mn |
| Sep 30, 2025 | -4.20 Mn |
| Jun 30, 2025 | -4.90 Mn |
| Jun 30, 2025 | -4.90 Mn |
| Mar 31, 2025 | -7.10 Mn |
| Mar 31, 2025 | -7.10 Mn |
| Dec 31, 2024 | -5.42 Mn |
| Dec 31, 2024 | -5.42 Mn |
| Sep 30, 2024 | -4.95 Mn |
| Sep 30, 2024 | -4.95 Mn |
| Jun 30, 2024 | -5.49 Mn |
| Jun 30, 2024 | -5.49 Mn |
| Mar 31, 2024 | -3.83 Mn |
| Mar 31, 2024 | -3.83 Mn |
| Dec 31, 2023 | -5.19 Mn |
| Dec 31, 2023 | -5.19 Mn |
| Sep 30, 2023 | -13.52 Mn |
| Sep 30, 2023 | -13.52 Mn |
| Jun 30, 2023 | -5.17 Mn |
| Jun 30, 2023 | -5.17 Mn |
| Mar 31, 2023 | -3.11 Mn |
| Mar 31, 2023 | -3.11 Mn |
| Dec 31, 2022 | -3.88 Mn |
| Dec 31, 2022 | -3.88 Mn |
| Sep 30, 2022 | -8.60 Mn |
| Sep 30, 2022 | -8.60 Mn |
| Jun 30, 2022 | -268,679.00 |
| Jun 30, 2022 | -268,679.00 |
| Mar 31, 2022 | -465,131.00 |
| Mar 31, 2022 | -465,131.00 |